Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/02/011879
CTRI/2018/02/011879
Completed
未知

Safety and efficacy of hyperthermic intra peritoneal chemotherapy (HIPEC) in management of gall bladder carcinoma

I0 sites45 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Carcinoma gall bladder

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Carcinoma gall bladder
Sponsor
I
Enrollment
45
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 31, 2020
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • •patients with gall bladder carcinoma undergoing surgery.

Exclusion Criteria

  • •Patients found to have widespread metastases( not amneable to cytoreduction) during surgery.
  • •Unresectable disease.
  • •Unfit for surgery.
  • •Developing hemodynamic instability during the procedure.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Study of Intraperitoneal chemotherapy in gastric cancer:Health Condition 1: null- Gastric Cancer
CTRI/2018/01/011056AIIMS
Active, not recruiting
Not Applicable
Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy. - HIPEC-ovarian carcinomaInclusion criteria :1. Histologically confirmed ovarian carcinoma or primary peritoneal carcinoma or Fallopian tube carcinoma.2. FIGO stage III disease or only pleural stage IV disease3. Age less than 65 years4. ECOG performance status 0-1.5. Adequate bone marrow, hepatic and renal functions.6. No serious cardiac or respiratory illness
EUCTR2009-009467-59-BEInstitut Jules Bordet
Not yet recruiting
Phase 3
EFFIPEC
2024-516224-34-00Uppsala University163
Active, not recruiting
Phase 1
EFFIPECColorectal cancerMedDRA version: 27.0Level: LLTClassification code: 10052362Term: Metastatic colorectal cancer Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2024-516224-34-00ppsala University230
Active, not recruiting
Phase 1
Feasibility of a chemotherapy with the two agents Carboplatin and Paclitaxel, that is applied heated directly into the abdomen after surgery of patients with advanced cancer of the ovaryOtherwise treatment-naive patients with epithelial ovarian cancer, FIGO III - IVaTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-003244-76-ATMedical University of Vienna20